Impax to Report First Quarter 2015 Results on May 11, 2015
April 16, 2015
Deadline Upcoming in $8 Million Settlement in the Impax Laboratories Inc (NASDAQ: IPXL) Investor Lawsuit
March 02, 2015
San Diego, CA -- (ReleaseWire) -- 03/02/2015 -- A deadline is coming up on July 15, 2015 in the settlement reached in the securities class action lawsuit filed on behalf of investors who purchased... Read More
Impax Revenues Increased 30% to $131 Million in Fourth Quarter 2014
February 24, 2015
Impax to Report Fourth Quarter 2014 Results on February 24, 2015
January 29, 2015
Impax Receives FDA Approval for a Generic Version of Lamictal® Orally Disintegrating Tablets (ODT)
January 26, 2015
Trending Now: New Research on Aeropostale, Impax, Facebook, TripAdvisor and BIND Therapeutics
January 09, 2015
Impax Pharmaceuticals Announce FDA Approval of RYTARY™ (Carbidopa and Levodopa) Extended-Release Capsules for the Treatment of Parkinson's disease
January 08, 2015
San Diego, CA -- (ReleaseWire) -- 12/16/2014 -- An investor who currently hold shares of Impax Laboratories Inc (NASDAQ:IPXL) filed a lawsuit against certain Impax Laboratories directors over alleged... Read More
Alert: Investor Who Hold Shares of Impax Laboratories Inc (NASDAQ:IPXL) Should Contact the Shareholders Foundation
November 19, 2014
San Diego, CA -- (SBWIRE) -- 11/19/2014 -- An investigation on behalf of investors, who currently hold shares of Impax Laboratories Inc (NASDAQ:IPXL), was announced over potential breaches of fiduciary... Read More
Pharma Equities Technical Data - Salix Pharma, AstraZeneca, Novartis, Impax Laboratories, and Novo Nordisk
November 11, 2014
Impax Laboratories to Present at the 2014 Credit Suisse Healthcare Conference on November 11
November 10, 2014
Impax Submits Marketing Authorization Application to EMA for IPX066 (Carbidopa-Levodopa) Extended-Release Capsules
November 06, 2014
Impax's Third Quarter 2014 Revenues Increased 19% to $158 Million
November 04, 2014
-- Third Quarter 2014 Adjusted Diluted EPS Increased to $0.33; GAAP Diluted EPS Increased to $0.22 -- Read More
IPXL Shareholder Alert: Do You Own Stock in IMPAX Laboratories Inc.?
November 03, 2014
Impax Announces R&D Reorganization Designed to Yield Process Improvements and Efficiencies
October 30, 2014
Impax Announces Departure of Carole Ben-Maimon, M.D., President of Global Pharmaceuticals
October 22, 2014
CORRECTING and REPLACING -- SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Impax Laboratories, Inc. of Class Action Lawsuit and Upcoming Deadline -- IPXL
October 10, 2014
Impax To Acquire Tower Holdings, Inc. And Lineage Therapeutics Inc.
October 09, 2014
-- Acquisitions includes operating subsidiaries CorePharma, LLC and Amedra Pharmaceuticals LLC -- Read More
Impax Laboratories Inc (NASDAQ:IPXL) Long-Term Investor Alert: Lawsuit Against Directors Filed
October 08, 2014
San Diego, CA -- (SBWIRE) -- 10/08/2014 -- The Shareholders Foundation announces that an investor, who currently holds shares of Impax Laboratories Inc (NASDAQ:IPXL), filed a lawsuit against certain... Read More
INVESTOR ALERT: Glancy Binkow & Goldberg LLP Announces Update to the Shareholder Lawsuit Against Impax Laboratories, Inc.
October 07, 2014
Lieff Cabraser Reminds Impax Laboratories, Inc. Investors of Upcoming Deadline in Class Action Litigation – IPXL
October 07, 2014
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline in the Class Action Lawsuit Against Impax Laboratories, Inc.
October 06, 2014
UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Impax Laboratories, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of October 13, 2014
October 03, 2014
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here